IMD-0354 effects on human and murine breast cancer cells.

<p>Viability of MDA-MB-231 cells was assessed by MTT assay after treatment with IMD-0354 for 24 h (A), 48 h (B) and 72 h (C). Apoptotic cells as Annexin V-FITC+ cells analyzed by FACS of FL4T1 cells treated with IMD-0354 (D). Viability of 4T1 cells was assessed by MTT assay after treatment with IMD-0354 for 24 h (E), 48 h (F) and 72 h (G). Data are shown as mean ± SEM. **P-value < 0.01; ****P-value < 0.001.